La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !
Emergent BioSolutions Gestione
Gestione criteri di controllo 1/4
Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.
Informazioni chiave
Joe Papa
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | less than a year |
| Proprietà del CEO | n/a |
| Durata media del management | 1.5yrs |
| Durata media del Consiglio di amministrazione | 3.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Emergent BioSolutions: Speculative Buy Amid Potential Monkeypox Vaccine Approval
Aug 18Emergent BioSolutions Inc. (NYSE:EBS) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 02
Emergent BioSolutions: A Much-Needed Mid-Stage Turnaround In Process
Jul 15Emergent BioSolutions: High-Risk, High-Reward Strategic Turnaround
May 10New CEO Appointment A Clear Positive For Emergent BioSolutions
Feb 27Emergent BioSolutions: Q3 Numbers Leave Work To Be Done
Dec 18Emergent BioSolutions: Meaningful Debt, But Narcan Should Grow
Nov 23Emergent BioSolutions Is Clearly Risky, But The Reward Could Be Substantial
Aug 23Financial Woes Darken Emergent BioSolutions' Outlook (Rating Downgrade)
Aug 14Emergent BioSolutions: Making A Big Bet On Narcan
Jul 21An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 30% Undervalued
Jun 22Is Emergent BioSolutions (NYSE:EBS) Using Too Much Debt?
Apr 05Emergent Biosolutions Q4 2022 Earnings Preview
Feb 24An Intrinsic Calculation For Emergent BioSolutions Inc. (NYSE:EBS) Suggests It's 39% Undervalued
Feb 16Emergent BioSolutions to offload travel health business to Bavarian Nordic for $380M
Feb 15Emergent BioSolutions: No Change To Thesis Following Latest Numbers, Recent Developments
Dec 07Emergent plunges 30% on quarterly earnings miss, lowers full-year guidance
Nov 09Emergent doses first participant in Phase 1 trial for Lassa virus vaccine
Sep 06Emergent BioSolutions: Now Long Through Sale Of October Put Spreads
Aug 24A Look At The Fair Value Of Emergent BioSolutions Inc. (NYSE:EBS)
Aug 13Additional 135M COVID-19 vaccine doses destroyed at Emergent BioSolutions Baltimore plant
Aug 12AMMINISTRATORE DELEGATO
Joe Papa (68 yo)
less than a year
Mandato
Mr. Joseph C. Papa, Jr. also known as Joe, serves as Executive Advisor at Water Street Healthcare Partners, LLC since joining in June 13, 2023. He serves as Chairman at SparingVision SAS since March 2023....
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Executive VP | 6.4yrs | US$2.18m | 0.29% $ 1.9m | |
| Executive VP of External Affairs | 1.4yrs | US$2.13m | 0.35% $ 2.3m | |
| Executive Vice President of Global Quality and Ethics & Compliance | 2.3yrs | US$1.68m | 0.31% $ 2.0m | |
| Senior Vice President of Products Business | 1.6yrs | US$1.06m | 0.046% $ 294.4k | |
| CEO, President & Director | less than a year | Nessun dato | Nessun dato | |
| Senior VP & Chief Human Resource Officer | 1.4yrs | Nessun dato | Nessun dato | |
| Senior VP | 1.4yrs | Nessun dato | Nessun dato | |
| Senior VP of Science & Development | 1.6yrs | Nessun dato | Nessun dato | |
| Senior Vice President of Manufacturing & Bioservices | no data | Nessun dato | 0.091% $ 582.1k |
1.5yrs
Durata media
57yo
Età media
Gestione esperta: Il team dirigenziale di EBS non è considerato esperto (durata media 1.5 anni), il che suggerisce un nuovo team.
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| CEO, President & Director | less than a year | Nessun dato | Nessun dato | |
| Independent Director | 18.2yrs | US$400.23k | 0.10% $ 646.4k | |
| Independent Director | 19.6yrs | US$394.73k | 0.037% $ 240.0k | |
| Independent Director | less than a year | US$397.50k | Nessun dato | |
| Independent Director | 2.3yrs | US$396.99k | 0.011% $ 69.3k | |
| Independent Director | 3.8yrs | US$405.98k | 0.032% $ 206.9k | |
| Independent Non-Executive Chairman | 20yrs | US$535.98k | 0.072% $ 460.4k | |
| Independent Director | 7.8yrs | US$413.48k | 0.070% $ 448.3k | |
| Independent Director | less than a year | US$398.75k | Nessun dato | |
| Independent Director | 2.1yrs | US$382.23k | 0.0075% $ 47.8k |
3.1yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di EBS sono considerati esperti (durata media dell'incarico 3.1 anni).